Autologous CD133(+) Cells as an Adjuvant to Below the Knee (BTK) Percutaneous Transangioplasty (PTA)
Condition:   Peripheral Arterial Disease Interventions:   Biological: G-CSF + CD133(+) cells;   Biological: G-CSF;   Procedure: percutaneous transluminal angioplasty (PTA);   Biological: Placebo infusion Sponsor:   Shanghai 10th People's Hospital Recruiting - verified September 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 22, 2016 Category: Research Source Type: clinical trials

Autologous CD133(+) Cells as an Adjuvant to Below the Knee Percutaneous Transluminal Angioplasty
Condition:   Peripheral Arterial Disease Interventions:   Biological: G-CSF + CD133(+) cells;   Biological: G-CSF;   Procedure: percutaneous transluminal angioplasty (PTA);   Biological: Placebo infusion Sponsor:   Shanghai 10th People's Hospital Recruiting - verified September 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 22, 2016 Category: Research Source Type: clinical trials